Huntsman opened lower at $9.76, compared with its previous close of $9.78. In the last trading session, the stock traded between $9.61 and $9.87. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Huntsman is now worth
$ 28.64
Resulting in a loss of
$ 71.36 (71.36%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 12 Analysts
Buy
25%
Hold
58.33%
Sell
16.67%
Markets Today
Today's Change
$-0.13 (-1.37%)
Day High
$9.87
Day Low
$9.61
Day Open
$9.76
Prev Close
$9.78
Volume
12,15,067
1W Return
-2.89%
1M Return
19.60%
3M Return
-7.60%
6M Return
-35.00%
1Y Return
12.56%
Fundamentals
Market Cap ($ Mn)
1,691
PE Ratio
-
PB Ratio
0.60
PEG Ratio
-
ROE
-3.17%
ROCE
0.69%
EPS (TTM)
$-0.10
Investment Returns
1 Week
-2.89%
1 Month
19.60%
3 Months
-7.60%
6 Months
-35.00%
9 Months
-31.39%
Financials
Quarterly
All values in $ Mn
1.5K
Jun 25
1.5K
Sep 25
1.4K
Dec 25
1.4K
Mar 26
1.7K
Jun 26
1.7K
Sep 26
Updates
12Nov
Huntsman declares $0.0875 per share dividend for Q4 2026
Huntsman declared a $0.0875 per share cash dividend for Q4 2026. Payment date is set for December 11, 2026. Shareholders of record as of November 27, 2026 are eligible. Company reported ~$6 billion in 2025 revenues from continuing operations.
Yesterday
9Nov
Keybanc maintains Overweight on Huntsman, lifts price target to $13
Keybanc analyst Salvator Tiano maintained Overweight rating on Huntsman. Price target raised from $12 to $13.
3 days ago
5Nov
UBS raises Huntsman price target to $10, maintains Neutral rating
UBS raised Huntsman price target from $9 to $10. UBS maintained a Neutral rating on the stock. Barclays previously raised its target to $11 with Equal-Weight.
8 days ago
3Nov
Huntsman Q3FY26 Results: Free cash flow falls to $82M
Free cash flow declined to $82 million from $157 million YoY. Adjusted EBITDA rose 40% to $132 million despite cash flow dip. Revenue grew 17.60% to $1.717 billion, beating consensus by 6.43%. Polyurethanes segment EBITDA surged 56.25% to $75 million.
10 days ago
6Oct
UBS lowers Huntsman price target to $9, maintains Neutral rating
UBS lowers Huntsman price target from $10 to $9. Rating maintained as Neutral by analyst Joshua Spector. Citigroup previously cut target from $11 to $9, also Neutral. No specific operational metrics cited for the downgrades.
1mo ago
31Jul
Huntsman Q2 Results: Sales rise 14% YoY to $1.663 billion
Huntsman delivered a strong second quarter with sales of $1.663 billion, beating estimates by 3.57% and rising 14.06% year-over-year from $1.458 billion.
